Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions

Edit Ambrus, Mária Rajtár, Katalin Ormándi, Teréz Séra, Anna Tószegi, Jeno Láng, L. Pávics, L. Csernay

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Among several investigative methods currently undergoing evaluation for the differentiation of biological features of breast mass lesions, mammoscintigraphy with different radiopharmaceuticals appears promising. This study evaluated the efficiency of 99m-Tc MIBI and 99m-Tc(V) DMSA mammoscintigraphy in the detection of malignant focal breast lesions. Mammography, ultrasonography, 99m-Tc MIBI and 99m-Tc(V) DMSA mammoscintigraphy were performed in 51 women with palpable breast mass lesions. Following surgical removal of the abnormalities, histological examination revealed 40 malignant and 11 benign breast mass lesions. In mammoscintigraphy, early (5 minute p.i. of MIBI, 2 hours p.i. of DMSA) and late (2 hours p.i. of MIBI and 5 hours p.i. of DMSA) planar images of the breast and the axillary regions were evaluated visually and quantitatively. The efficacy of the methods was assessed via ROC curves and variance analysis. The visual scores and the quantitative T/NT values with MIBI demonstrated a significant difference between malignant and benign breast mass lesions. A significant difference was also found as concerns the grade of malignancy from the MIBI accumulation. The late MIBI images seemed optimal. The DMSA values indicated no relationship with the breast lesion malignancy. In the detection of metastatic lymph node involvement, the sensitivity and specificity with mammography and ultrasonography were 57% and 85%, with MIBI 53% and 81%, and with DMSA 53% and 95%, respectively. It is concluded that MIBI (2 hours p.i.) mammoscintigraphy is a useful and simple method for differentiation of malignant breast abnormalities from benign lesions and for determination of the grade of malignancy. DMSA mammoscintigraphy appears superior to MIBI only in the detection of axillary lymph node metastases.

Original languageEnglish
Pages (from-to)1599-1605
Number of pages7
JournalAnticancer Research
Volume17
Issue number3 B
Publication statusPublished - 1997

Fingerprint

Succimer
Technetium Tc 99m Sestamibi
Radionuclide Imaging
Breast
Mammography
ROC Curve
Ultrasonography
Lymph Nodes
Neoplasms
Radiopharmaceuticals
Analysis of Variance
Neoplasm Metastasis
Sensitivity and Specificity

Keywords

  • 99m-Tc MIBI
  • 99m-Tc(V) DMSA
  • Breast mass lesion
  • Grade of malignancy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ambrus, E., Rajtár, M., Ormándi, K., Séra, T., Tószegi, A., Láng, J., ... Csernay, L. (1997). Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions. Anticancer Research, 17(3 B), 1599-1605.

Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions. / Ambrus, Edit; Rajtár, Mária; Ormándi, Katalin; Séra, Teréz; Tószegi, Anna; Láng, Jeno; Pávics, L.; Csernay, L.

In: Anticancer Research, Vol. 17, No. 3 B, 1997, p. 1599-1605.

Research output: Contribution to journalArticle

Ambrus, E, Rajtár, M, Ormándi, K, Séra, T, Tószegi, A, Láng, J, Pávics, L & Csernay, L 1997, 'Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions', Anticancer Research, vol. 17, no. 3 B, pp. 1599-1605.
Ambrus E, Rajtár M, Ormándi K, Séra T, Tószegi A, Láng J et al. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions. Anticancer Research. 1997;17(3 B):1599-1605.
Ambrus, Edit ; Rajtár, Mária ; Ormándi, Katalin ; Séra, Teréz ; Tószegi, Anna ; Láng, Jeno ; Pávics, L. ; Csernay, L. / Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions. In: Anticancer Research. 1997 ; Vol. 17, No. 3 B. pp. 1599-1605.
@article{05796e8f1e2b47b2812bf9f25c5836f9,
title = "Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions",
abstract = "Among several investigative methods currently undergoing evaluation for the differentiation of biological features of breast mass lesions, mammoscintigraphy with different radiopharmaceuticals appears promising. This study evaluated the efficiency of 99m-Tc MIBI and 99m-Tc(V) DMSA mammoscintigraphy in the detection of malignant focal breast lesions. Mammography, ultrasonography, 99m-Tc MIBI and 99m-Tc(V) DMSA mammoscintigraphy were performed in 51 women with palpable breast mass lesions. Following surgical removal of the abnormalities, histological examination revealed 40 malignant and 11 benign breast mass lesions. In mammoscintigraphy, early (5 minute p.i. of MIBI, 2 hours p.i. of DMSA) and late (2 hours p.i. of MIBI and 5 hours p.i. of DMSA) planar images of the breast and the axillary regions were evaluated visually and quantitatively. The efficacy of the methods was assessed via ROC curves and variance analysis. The visual scores and the quantitative T/NT values with MIBI demonstrated a significant difference between malignant and benign breast mass lesions. A significant difference was also found as concerns the grade of malignancy from the MIBI accumulation. The late MIBI images seemed optimal. The DMSA values indicated no relationship with the breast lesion malignancy. In the detection of metastatic lymph node involvement, the sensitivity and specificity with mammography and ultrasonography were 57{\%} and 85{\%}, with MIBI 53{\%} and 81{\%}, and with DMSA 53{\%} and 95{\%}, respectively. It is concluded that MIBI (2 hours p.i.) mammoscintigraphy is a useful and simple method for differentiation of malignant breast abnormalities from benign lesions and for determination of the grade of malignancy. DMSA mammoscintigraphy appears superior to MIBI only in the detection of axillary lymph node metastases.",
keywords = "99m-Tc MIBI, 99m-Tc(V) DMSA, Breast mass lesion, Grade of malignancy",
author = "Edit Ambrus and M{\'a}ria Rajt{\'a}r and Katalin Orm{\'a}ndi and Ter{\'e}z S{\'e}ra and Anna T{\'o}szegi and Jeno L{\'a}ng and L. P{\'a}vics and L. Csernay",
year = "1997",
language = "English",
volume = "17",
pages = "1599--1605",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3 B",

}

TY - JOUR

T1 - Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions

AU - Ambrus, Edit

AU - Rajtár, Mária

AU - Ormándi, Katalin

AU - Séra, Teréz

AU - Tószegi, Anna

AU - Láng, Jeno

AU - Pávics, L.

AU - Csernay, L.

PY - 1997

Y1 - 1997

N2 - Among several investigative methods currently undergoing evaluation for the differentiation of biological features of breast mass lesions, mammoscintigraphy with different radiopharmaceuticals appears promising. This study evaluated the efficiency of 99m-Tc MIBI and 99m-Tc(V) DMSA mammoscintigraphy in the detection of malignant focal breast lesions. Mammography, ultrasonography, 99m-Tc MIBI and 99m-Tc(V) DMSA mammoscintigraphy were performed in 51 women with palpable breast mass lesions. Following surgical removal of the abnormalities, histological examination revealed 40 malignant and 11 benign breast mass lesions. In mammoscintigraphy, early (5 minute p.i. of MIBI, 2 hours p.i. of DMSA) and late (2 hours p.i. of MIBI and 5 hours p.i. of DMSA) planar images of the breast and the axillary regions were evaluated visually and quantitatively. The efficacy of the methods was assessed via ROC curves and variance analysis. The visual scores and the quantitative T/NT values with MIBI demonstrated a significant difference between malignant and benign breast mass lesions. A significant difference was also found as concerns the grade of malignancy from the MIBI accumulation. The late MIBI images seemed optimal. The DMSA values indicated no relationship with the breast lesion malignancy. In the detection of metastatic lymph node involvement, the sensitivity and specificity with mammography and ultrasonography were 57% and 85%, with MIBI 53% and 81%, and with DMSA 53% and 95%, respectively. It is concluded that MIBI (2 hours p.i.) mammoscintigraphy is a useful and simple method for differentiation of malignant breast abnormalities from benign lesions and for determination of the grade of malignancy. DMSA mammoscintigraphy appears superior to MIBI only in the detection of axillary lymph node metastases.

AB - Among several investigative methods currently undergoing evaluation for the differentiation of biological features of breast mass lesions, mammoscintigraphy with different radiopharmaceuticals appears promising. This study evaluated the efficiency of 99m-Tc MIBI and 99m-Tc(V) DMSA mammoscintigraphy in the detection of malignant focal breast lesions. Mammography, ultrasonography, 99m-Tc MIBI and 99m-Tc(V) DMSA mammoscintigraphy were performed in 51 women with palpable breast mass lesions. Following surgical removal of the abnormalities, histological examination revealed 40 malignant and 11 benign breast mass lesions. In mammoscintigraphy, early (5 minute p.i. of MIBI, 2 hours p.i. of DMSA) and late (2 hours p.i. of MIBI and 5 hours p.i. of DMSA) planar images of the breast and the axillary regions were evaluated visually and quantitatively. The efficacy of the methods was assessed via ROC curves and variance analysis. The visual scores and the quantitative T/NT values with MIBI demonstrated a significant difference between malignant and benign breast mass lesions. A significant difference was also found as concerns the grade of malignancy from the MIBI accumulation. The late MIBI images seemed optimal. The DMSA values indicated no relationship with the breast lesion malignancy. In the detection of metastatic lymph node involvement, the sensitivity and specificity with mammography and ultrasonography were 57% and 85%, with MIBI 53% and 81%, and with DMSA 53% and 95%, respectively. It is concluded that MIBI (2 hours p.i.) mammoscintigraphy is a useful and simple method for differentiation of malignant breast abnormalities from benign lesions and for determination of the grade of malignancy. DMSA mammoscintigraphy appears superior to MIBI only in the detection of axillary lymph node metastases.

KW - 99m-Tc MIBI

KW - 99m-Tc(V) DMSA

KW - Breast mass lesion

KW - Grade of malignancy

UR - http://www.scopus.com/inward/record.url?scp=0030976775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030976775&partnerID=8YFLogxK

M3 - Article

C2 - 9179201

AN - SCOPUS:0030976775

VL - 17

SP - 1599

EP - 1605

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3 B

ER -